Authors


Konrad Reinhart, MD

Latest:

Sepsis and Antimicrobial Resistance Awareness Gain Ground, But Action Must Continue

As antimicrobial therapies become less effective, more people are at risk for infections that can progress to sepsis.


Hermione Hurley, MD, MBChB

Latest:

With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases

Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.


Lindsay Courtney, PharmD

Latest:

Two Allergies or Cross-Reactive?

The story of penicillin and cefazolin.


Julie Ann Justo, PharmD, MS

Latest:

“Triple Therapy” Facing Triple Threat

Clinicians provide an overview of intraamniotic infections and offer treatment strategies for these challenging infections.


Jamie Wagner, PharmD, BCPS

Latest:

A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.


Daniel Anderson, PharmD

Latest:

Intravenous Fosfomycin for Systemic Multidrug-Resistant Infections

Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.


Thomas M File, Jr. MD, MSc, MACP, FIDSA, FCCP

Latest:

Thomas M. File, Jr., MD: COVID-19 Requires a Unified Approach

In addition to providing important expertise into the management of this infection, our role in educating the public—in many cases providing an important perspective when fears tend to run high—is also essential.


NATALIE DICENZO

Latest:

Never Ignore a New Rash in a Patient With AIDS

A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.



Kirk E. Hevener, PharmD, PhD

Latest:

Bioaccumulation of Drugs by Human Gut Bacteria Can Affect Drug Availability

A new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.


Amy Jacob

Latest:

Pfizer's C. difficile Vaccine Succeeds in Phase II Study

Researchers found the experimental vaccine could potentially inhibit severe diarrhea and pseudomembranous colitis by inducing a functional antibody response that can neutralize the two main disease-causing toxins (toxin A or B) produced by C. difficile.


MD Magazine staff

Latest:

Researchers Are Working on a Promising Novel Herpes Vaccine

Albert Einstein College of Medicine researchers have developed a new vaccine type that shows promise to possibly become the first ever for preventing genital herpes.


Eric S. Daar, MD

Latest:

HIV Treatment Advice for Community Physicians

Experts provide community physicians treating HIV with practical advice for screening, diagnosing, and managing patients with HIV.


BY HELEN W. BOUCHER, MD, FACP, FIDSA

Latest:

Have we made progress in the 10 X' 20 Initative?

IDSA reached its goal, but nobody’s buying. Can the drowning antimicrobial pipeline be saved?


Gina Battaglia, PhD

Latest:

Hepatitis C Virus: Task Shifting and Screening

Clinicians discuss screening and treatment approaches for the disease.


Sandy Estrada, PharmD

Latest:

Addressing Shortcomings in Infection and Sepsis Treatment Should Be Top of the Priority List

As clinicians and health care executives work to strike a balance between reducing costs and improving clinical outcomes, the importance of sepsis identification and treatment cannot be underscored enough, and starts with evaluating current practices for infection management.


Jennifer Gershman, PharmD, CPh

Latest:

The Public Health Threat of Ice Cream Tampering

Videos of individuals licking ice cream and placing these cartons back on freezer store shelves have gone viral, and this practice can pose public health risks.


Katie E. Barber, PharmD*

Latest:

Using IL-6 Inhibitors to Treat COVID-19

Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.



Nicola M. Parry, BVSc, MRCVS, MSc, DipACVP

Latest:

Genomic Features of the 2015 Elizabethkingia Outbreak

Researchers from Pasteur Institute, Paris, France, and the Centers of Disease Control and Prevention, examine the genomic features of the E. anophelis strain behind the 2015-2016 Wisconsin outbreak.


Jacquelyn Gray

Latest:

New Line of HIV Treatment Identified for Patients Ineligible for Efavirenz

A national clinical trial has found non-efavirenz antiretroviral therapy effective as a first-line treatment, which is good news for patients with HIV who are ineligible to usea the common drug.


Toni Campanella, PharmD*

Latest:

COVID-19 Complicates an Already Difficult Presentation of Infective Endocarditis

Final Diagnosis: Infective Endocarditis Due to Granulicatella adiacens and Streptococcus mitis.



Jaclyn Rosenzweig, MD

Latest:

A Case of CNS Nocardia farcinica Presenting as Aphasia in an Immunocompetent Host

Quick recognition is key to early initiation of treatment and long-term survival.


Becky Jayakumar, PharmD

Latest:

Clinical Outcomes of Vancomycin Mono or Combination Therapy with a Beta-Lactam Against MRSA Bacteremia

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high mortality.


JACK JACOB, DO

Latest:

The Case of Late Aspergillus Fumigatus Infection of Implantable Cardioverter Defibrillator Leads

Quick action was needed against this very rare cause of fungal endocarditis.


Katherine Lusardi, PharmD, BCPS-AQ ID, BCIDP*

Latest:

Daptomycin Dosing in Obesity: Consideration for a Fixed-Dose Strategy

This In the Literature piece considers a fixed-dose strategy for administering daptomycin in obese patients.


Ricardo A. Camargo, PharmD Candidate

Latest:

Treating Outpatient Cystitis in the Era of Antimicrobial Resistance

What can clinicians do now that increasing resistance has limited oral treatment options for outpatient cystitis?


Kerry Cleveland, MD, FACP, FIDSA, FSHEA

Latest:

Acute Bacterial Skin and Skin Structure Infections: A Modernized Approach

The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.


Elizabeth B. Hirsch, PharmD, RPH, FIDSA

Latest:

What's New In 2024: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing had its series of meetings to update breakpoints for a variety of classes of antimicrobials.

© 2025 MJH Life Sciences

All rights reserved.